Publications

Publications, Books, Book Chapters and Reviews by Prof. Marcus Maurer, MD

Use: Start with an overview of all publications. Use tag links to list selected documents or to list an entire category, e.g. Original Work, Books, Book Chapters, Reviews. If you know what you are looking for, enter this term in the search field.

Targeted next-generation sequencing for the molecular diagnosis of hereditary angioedema due to C1-inhibitor deficiency

Filename 314. Loules et al., Targ. next-gen. HAE,Gene 2018.pdf
Filesize 728 KB
Version o.314
Date added June 12, 2020
Downloaded 0 times
Category Original Work
Tags angioedema, consensus, evidence-based, hives, wheal
Authors Loules, G., Zamanakou, M., Parsopoulou, F., Vatsiou, S., Psarros, F., Csuka, D., Porebski, G., Obtulowicz, K., Valerieva, A., Staevska, M., López-Lera, A., López-Trascasa, M., Moldovan, D., Magerl, M., Maurer, M. Speletas, M., Farkas, H., and Germenis, A. E.
Citation Loules, G., Zamanakou, M., Parsopoulou, F., Vatsiou, S., Psarros, F., Csuka, D., Porebski, G., Obtulowicz, K., Valerieva, A., Staevska, M., López-Lera, A., López-Trascasa, M., Moldovan, D., Magerl, M., Maurer, M. Speletas, M., Farkas, H., and Germenis, A. E.: Targeted next-generation sequencing for the molecular diagnosis of hereditary angioedema due to C1-inhibitor deficiency. Gene 2018: 667; 76-82.
Corresponding authors Loules, G.
DocNum O.314
DocType PDF
Edition; Page 667; 76-82
IF 2.64
Publisher Gene
ReleaseDate 2018

This evidence- and consensus-based guideline was developed following the methods recommended by Cochrane and the Grading of Recommendations Assessment, Devel- opment and Evaluation (GRADE) working group. The conference was held on 1 December 2016. It is a joint initiative of the Dermatology Section of the European Academy of Allergology and Clinical Immunology (EAACI), the EU-founded network of excellence, the Global Allergy and Asthma European Network (GA2LEN), the European Dermatology Forum (EDF) and the World Allergy Organization (WAO) with the partic- ipation of 48 delegates of 42 national and international societies. This guideline was acknowledged and accepted by the European Union of Medical Specialists (UEMS). Urticaria is a frequent, mast cell-driven disease, presenting with wheals, angioedema, or both. The lifetime prevalence for acute urticaria is approximately 20%. Chronic spontaneous urticaria and other chronic forms of urticaria are disabling, impair quality of life and affect performance at work and school. This guideline covers the definition and classification of urticaria, taking into account the recent progress in identifying its causes, eliciting factors and pathomechanisms. In addition, it outlines evidence-based diagnostic and therapeutic approaches for the different subtypes of urticaria.

(Last update: 08.2021)

Number of publications (original work and reviews) in peer-reviewed journals: 636
Number of original publications in peer-reviewed journals: 462
Number of reviews in peer-reviewed journals: 174
Cumulative IF of publications (original work & reviews) in peer-reviewed journals: 3834,12
Cumulative IF for original publications in peer-reviewed journals: 3043,14
Cumulative IF for reviews in peer-reviewed journals: 790,98
Citations, Hirsch index: (view on Web of Science) 26429